Literature DB >> 7645205

Cells resistant to interferon-beta respond to interferon-gamma via the Stat1-IRF-1 pathway.

E M Coccia1, G Marziali, E Stellacci, E Perrotti, R Ilari, R Orsatti, A Battistini.   

Abstract

The mechanism responsible for the induction of the 2-5A synthetase gene by Interferon-gamma (IFN-gamma) (type II) was studied in Friend leukemia cells. It was previously shown that activation of 2-5A synthetase gene expression by IFN-gamma in the 3Cl8 cell, a clone resistant to IFN-alpha,beta (type I), correlates with the formation of two major complexes, designated Fg and Fc, that bind to the interferon-stimulated responsive element of the gene. Conversely, in a clone resistant to both types of IFNs (3 gamma R8), no induction of DNA-protein complexes or of 2-5A synthetase gene expression was detected. In the present report the Fg complex has been characterized as including the interferon regulatory factor 1 (IRF-1), whereas the Fc factor, present also in control cells, has been characterized as composed of IRF-2. Incubation of cell extracts with antibodies to IRF-1 abolishes the formation of the Fg complex, and antibodies to IRF-2 abolish the formation of the Fc complex. Moreover, in the 3Cl8 cell, IFN-gamma is able to induce in few minutes the formation of a complex between a DNA element identified as the IFN-gamma activation site (GAS), present on the IRF-1 gene promoter, and the STAT1 protein. These findings suggest that in cells resistant to type I IFN, IFN-gamma is able, through the activation of the STAT1 protein, to induce the expression of the IRF-1 factor which in turn seems to be sufficient to transactivate the 2-5A synthetase gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7645205     DOI: 10.1006/viro.1995.1384

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Interferon regulatory factor expression in human breast cancer.

Authors:  G M Doherty; L Boucher; K Sorenson; J Lowney
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

2.  Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha.

Authors:  Vladimir Hurgin; Daniela Novick; Ariel Werman; Charles A Dinarello; Menachem Rubinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-08       Impact factor: 11.205

3.  Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation.

Authors:  E M Coccia; E Stellacci; M Valtieri; B Masella; T Feccia; G Marziali; J Hiscott; U Testa; C Peschle; A Battistini
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

4.  Enterovirus 71 Proteins 2A and 3D Antagonize the Antiviral Activity of Gamma Interferon via Signaling Attenuation.

Authors:  Li-Chiu Wang; Su-O Chen; Shih-Ping Chang; Yi-Ping Lee; Chun-Keung Yu; Chia-Ling Chen; Po-Chun Tseng; Chia-Yuan Hsieh; Shun-Hua Chen; Chiou-Feng Lin
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

5.  Presence of interferon regulatory factor-1 in aggressive and nonaggressive histological variants of Basal cell carcinoma specimens.

Authors:  Nurten Turhan-Haktanir; F Husniye Dilek; Yavuz Demir; Onder Sahin
Journal:  J Cutan Aesthet Surg       Date:  2010-01

6.  Characterization of the 5'-flanking region and regulation of expression of human anion exchanger SLC26A6.

Authors:  Seema Saksena; Alka Dwivedi; Amika Singla; Ravinder K Gill; Sangeeta Tyagi; Alip Borthakur; Waddah A Alrefai; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

7.  Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression.

Authors:  J C Blanco; C Contursi; C A Salkowski; D L DeWitt; K Ozato; S N Vogel
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

8.  Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.

Authors:  T Fehr; G Schoedon; B Odermatt; T Holtschke; M Schneemann; M F Bachmann; T W Mak; I Horak; R M Zinkernagel
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.